Price T Rowe Associates Inc Health Catalyst, Inc. Transaction History
Price T Rowe Associates Inc
- $816 Billion
- Q1 2024
A detailed history of Price T Rowe Associates Inc transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 49,746 shares of HCAT stock, worth $303,450. This represents 0.0% of its overall portfolio holdings.
Number of Shares
49,746
Previous 46,915
6.03%
Holding current value
$303,450
Previous $435,000
13.79%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding HCAT
# of Institutions
181Shares Held
47.6MCall Options Held
2.52MPut Options Held
10.8K-
Black Rock Inc. New York, NY5.36MShares$32.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.48MShares$27.3 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA2.63MShares$16 Million0.0% of portfolio
-
Daventry Group, LP New York, NY2.16MShares$13.2 Million6.51% of portfolio
-
Impax Asset Management Group PLC2.15MShares$13.1 Million0.07% of portfolio
About Health Catalyst, Inc.
- Ticker HCAT
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 54,723,400
- Market Cap $334M
- Description
- Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...